Top message

Contributing to sustainable social development through business activities.

President, Representative Director, and CEO Gyo Sagara

Since its establishment in 1717, ONO has resolutely pushed forward in the pharmaceutical industry under the corporate philosophy "Dedicated to Man' s Fight against Disease and Pain." We aim to contribute to society by developing pharmaceutical products that truly benefits patients, and we will continue to tackle diseases that have not been overcome, as well as the disease areas where the satisfaction level with the treatment is still low among patients and medical needs are high.

As a company that delivers pharmaceutical products affecting the lives and quality of life of patients, we always engage with the community with a sincere and faithful attitude and making efforts to further strengthen our compliance system on a company-wide scale, so as not only to comply with laws and regulations but also to act in accordance with high ethical standards.

We set the ONO PHARMACEUTICAL Codes of Conduct as the basis of our CSR management and specified six priority areas for our CSR activities in light of the seven core subjects defined in ISO 26000, an international standard providing guidelines for social responsibility, and we have promoted the activities with company-wide efforts. The first of these priority areas is Corporate Governance, which forms the foundation for the five remaining areas of Innovative Pharmaceutical Products, Human Resources and Human Rights, The Environment, Fair Operating Practices, and Society. We will promote activities related to these priority areas to fulfill our social responsibility to all stakeholders and contribute to the sustainable development of society.